Cancer Journal

Papers
(The TQCC of Cancer Journal is 7. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-05-01 to 2026-05-01.)
ArticleCitations
Toxicities From Antibody-Drug Conjugates138
Social Drivers of Cancer Risk and Outcomes Among African American Men28
HER2 and HER3 as Therapeutic Targets in Head and Neck Cancer28
Oncology Physician Workforce Diversity26
PET Imaging of Metabolism, Perfusion, and Hypoxia24
Building a Bridge to Equity in Health and Health Care in Cancer Care24
Health Care Policy and Disparities in Health23
c-Met Signaling as a Therapeutic Target in Head and Neck Cancer21
Stereotactic Body Radiation Therapy21
Melanoma—Modern Treatment for Metastatic Melanoma20
Therapeutic Targeting of FGFR Signaling in Head and Neck Cancer19
Nonoperative Management for Rectal Cancer18
Evaluation of the Prognostic Role of Liver Metastases on Patient Outcomes18
Tumor-Infiltrating Lymphocyte and Other Cell Therapies for Metastatic Melanoma17
Germline Predisposition to Myelodysplastic Syndromes15
Metastatic Melanoma Treatment in Special Populations14
Aurora Kinases as Therapeutic Targets in Head and Neck Cancer14
Prostate Cancer, Race, and Health Disparity13
Rectal Cancer—The Only Constant Is Change13
Antibody Drug Conjugates in Multiple Myeloma13
Diversity in Cancer Care13
Primary Prevention of Cancer13
Current State of Neoadjuvant Therapy for Locally Advanced Rectal Cancer12
Overlooked and Damaging Impact of Structural Racism and Implicit Bias on US Health Care12
Hematopoietic Stem Cell Transplantation for Myelodysplastic Syndromes12
Advances in Stereotactic Body Radiation Therapy for Lung Cancer11
Overview of the Management of Higher-Risk Myelodysplastic Syndromes11
Effective Personalization of Stereotactic Radiosurgery for Brain Metastases in the Modern Era11
Updates in the Management of Uveal Melanoma11
New Metabolomic Insights Into Cancer10
Short- and Long-term Repercussions of Vancomycin on Immune Surveillance and the Efficacy of Antitumor Treatments10
Supportive Care for Patients With Myelodysplastic Syndromes10
Introduction10
Menopausal Hormone Therapy and Breast Cancer10
A General Approach to Patients Presenting With Locally Advanced or Distant Metastatic Disease10
Impact of Precision Medicine in Oncology9
How Far We’ve Come9
PI3K Inhibition for Squamous Cell Head and Neck Carcinoma9
Hormone Replacement Therapy After Breast Cancer8
Telemedicine and cancer care: Barriers and strategies to optimize delivery: Erratum8
Role of the Microbiome in Immunotherapy of Melanoma8
Evolving Landscape of Antibody Drug Conjugates in Lymphoma7
The Current Role of Human Papillomavirus Circulating Tumor DNA in Oropharynx Cancer7
Estrogen for the Treatment and Prevention of Breast Cancer7
Discovery of Natural Products for Cancer Prevention7
Survival of the Fittest7
What Role Does Radiotherapy Play in the Molecular Era for Intrahepatic Cholangiocarcinoma?7
Telehealth and Technology7
Spectrum From Clonal Hematopoiesis to Myelodysplastic Neoplasm/Syndromes and Other Myeloid Neoplasms7
Current State of Cell Therapies for Genitourinary Malignancies7
0.18446207046509